Education
About Us
Working with TipRanks
Follow Us
Dynavax Technologies Corp. (DVAX)
NASDAQ:DVAX
Total Valuation
Dynavax has a market cap or net worth of $1.44B. The enterprise value is $1.49B.
Market Cap$1.44B
Enterprise Value$1.49B
Share Statistics
Dynavax has 122,411,680 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding122,411,680
Owned by Insiders0.50%
Owned by Institutions0.22%
Financial Efficiency
Dynavax’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is -0.40%.
Return on Equity (ROE)0.05
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)-0.40%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee684.56K
Profits Per Employee67.43K
Employee Count405
Asset Turnover0.28
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Dynavax is 60.81. Dynavax’s PEG ratio is -0.12.
PE Ratio60.81
PS Ratio0.00
PB Ratio2.78
Price to Fair Value2.78
Price to FCF27.60
Price to Operating Cash Flow24.97
PEG Ratio-0.12
Income Statement
In the last 12 months, Dynavax had revenue of 277.25M and earned 27.31M in profits. Earnings per share was 0.21.
Revenue277.25M
Gross Profit277.25M
Operating Income-4.12M
Pretax Income30.86M
Net Income27.31M
EBITDA45.70M
Earnings Per Share (EPS)0.21
Cash Flow
In the last 12 months, operating cash flow was 66.51M and capital expenditures -6.35M, giving a free cash flow of 60.16M billion.
Operating Cash Flow66.51M
Free Cash Flow60.16M
Free Cash Flow per Share0.49
Dividends & Yields
Dynavax pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.30
52-Week Price Change-2.05%
50-Day Moving Average12.75
200-Day Moving Average12.09
Relative Strength Index (RSI)45.75
Average Volume (3m)2.54M
Important Dates
Dynavax upcoming earnings date is May 6, 2025, TBA Not Confirmed.
Last Earnings DateFeb 20, 2025
Next Earnings DateMay 6, 2025
Ex-Dividend Date―
Financial Position
Dynavax as a current ratio of 10.80, with Debt / Equity ratio of 42.63%
Current Ratio10.80
Quick Ratio9.91
Debt to Market Cap0.15
Net Debt to EBITDA3.38
Interest Coverage Ratio-0.61
Taxes
In the past 12 months, Dynavax has paid 3.55M in taxes.
Income Tax3.55M
Effective Tax Rate0.11
Enterprise Valuation
Dynavax EV to EBITDA ratio is 39.72, with an EV/FCF ratio of 30.17.
EV to Sales6.55
EV to EBITDA39.72
EV to Free Cash Flow30.17
EV to Operating Cash Flow27.29
Balance Sheet
Dynavax has $713.83M in cash and marketable securities with $12.85M in debt, giving a net cash position of -$459.42M billion.
Cash & Marketable Securities$713.83M
Total Debt$12.85M
Net Cash-$459.42M
Net Cash Per Share-$3.75
Tangible Book Value Per Share$4.57
Margins
Gross margin is 82.17%, with operating margin of -1.49%, and net profit margin of 9.85%.
Gross Margin82.17%
Operating Margin-1.49%
Pretax Margin11.13%
Net Profit Margin9.85%
EBITDA Margin16.48%
EBIT Margin13.58%
Analyst Forecast
The average price target for Dynavax is $24.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$24.75
Price Target Upside115.59% Upside
Analyst ConsensusModerate Buy
Analyst Count5
Revenue Growth Forecast19.36%
EPS Growth Forecast―